Hartman Vreit Xxi Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Hartman Vreit Xxi Inc (HART) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Hartman Vreit Xxi Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 13M vs 0M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (+0.4% annualized vs trailing 12 months).
- Peer revenue share: Hartman Vreit Xxi Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
HART Sales vs. its Competitors, Q4 2022
Hartman Vreit Xxi Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
Hartman Vreit Xxi Inc vs. its Competitors, Q4 2022
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Hartman Vreit Xxi Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Hartman Vreit Xxi Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Hartman Vreit Xxi Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (5) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Hartman Vreit Xxi Inc's competitor groups requires a Commercial License.
For context: the Real Estate Investment Trusts industry grew revenue -1.2% year over year, combined, vs 5.2% for Hartman Vreit Xxi Inc. Hartman Vreit Xxi Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Hartman Vreit Xxi Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Hartman Vreit Xxi Inc | No | Yes | Yes | No |
| Competitors combined (1) | - | - | - | |
| Similar Growth & Profitability (8) | 37.50 % (3 of 8) | 62.50 % (5 of 8) | 37.50 % (3 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
HART Stock Performance relative to its Competitors
HART Stock Performance relative to Similar Growth & Profitability Competitors
Publicly Traded Peers of Hartman Vreit Xxi Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Hartman Vreit Xxi Inc |
282.82 | 13.46 |
 United Health Products Inc |
10.45 | 0.00 |
| SUBTOTAL | 293.27 | 13.46 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Hartman Vreit Xxi Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Hartman Vreit Xxi Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Hartman Vreit Xxi Inc | 283 | - | - |
| United Health Products Inc | 10 | 41 | -142,248 |
| PEERS TOTAL | 10 | 41 | -142,248 |
Hartman Vreit Xxi Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 180 companies in Hartman Vreit Xxi Inc's industry classification, broader than the peer set above. Market cap in millions of $.Hartman Vreit Xxi Inc ranks #0 of 180 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 419, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Welltower Inc | 180,748 | 11.96 % |
| 2 | Prologis Inc | 123,136 | 8.15 % |
| 3 | Equinix Inc | 106,350 | 7.03 % |
| 4 | American Tower Corporation | 88,492 | 5.85 % |
| 5 | Simon Property Group inc | 1,234 | 5.2% |
| 6 | Digital Realty Trust Inc | 1,234 | 5.2% |
| 7 | Public Storage | 1,234 | 5.2% |
| 8 | Realty Income Corporation | 1,234 | 5.2% |
| 9 | Ventas inc | 1,234 | 5.2% |
| 10 | Crown Castle Inc | 1,234 | 5.2% |
| 0 | Hartman Vreit Xxi Inc | 282 | 0.00 % |
Market cap and industry share for the rest of Hartman Vreit Xxi Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2025-08-19.
Hartman Vreit Xxi Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Real Estate Investment Trusts industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (283 companies). See the full Real Estate Investment Trusts industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 71.53 % | 41.79 % (avg) | +29.7 pp |
| Operating Margin | -14.34 % | industry median | -40.6 pp |
| EBITDA Margin | 21.75 % | 38.25 % (avg) | -16.5 pp |
| Capital Intensity (Capex / Revenue) | 26.53 % | 28.35 % (avg) | -1.8 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Hartman Vreit Xxi Inc's Valuation vs Competitive Position
Valuation multiples vs the Real Estate Investment Trusts industry average (283 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Real Estate Investment Trusts industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 30.0x | - |
| EV / EBITDA | 98.8x | 17.5x | +81.3x |
| P/B | 4.5x | 1.9x | +2.6x |
| Return on Equity | -3.61 % | industry aggregate | -9.34 % |
| Return on Invested Capital | -1.21 % | 2.09 % (avg) | -3.30 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Hartman Vreit Xxi Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue Growth | - | 47.19 % | 46.23 % | 382.38 % | 74.22 % | -0.94 % | 4.31 % |
| Operating Margin | - | 54.53 % | -57.75 % | -14.51 % | -23.08 % | - | -14.34 % |
| Return on Invested Capital | -55.60 % | 7.06 % | -1.69 % | -0.95 % | -1.89 % | - | -1.21 % |
| P/E | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Hartman Vreit Xxi Inc's Strategic Group Map
Hartman Vreit Xxi Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Hartman Vreit Xxi Inc's trailing-12-month revenue growth of 4.3% and operating margin of -14.3% compares with an average of 1.9% growth and -13.5% margin across its 8 closest peers by combined growth, margin and ROIC -- Hartman Vreit Xxi Inc sits above that peer average on growth and below it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Hartman Vreit Xxi Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 419 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Moderate, in line with the industry | Capital intensity (capex / revenue) of 26.53 % vs industry average 28.35 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Hartman Vreit Xxi Inc's dedicated Suppliers and Customers pages, not here.
Hartman Vreit Xxi Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Hartman Vreit Xxi Inc falls in the Medium attractiveness / Low strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Hartman Vreit Xxi Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Operating margin 40.6 points below the industry median.
- Return on equity 9.3 points below the industry aggregate.
- Underperforming the U.S.A. 500 over the trailing 12 months.
Opportunities
- A meaningful share of competitors (100.00 %) show financial-distress signals, a possible opening to gain share.
Threats
No rule matched.
Methodology: see Methodology: SWOT Analysis.
Hartman Vreit Xxi Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Hartman Vreit Xxi Inc | 0.08 | 1.02 | 0.94 |
| United Health Products Inc | 0.00 | 0.02 | - |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Hartman Vreit Xxi Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Hartman Vreit Xxi Inc | Q4 2022 | +5.2 % | - |
| United Health Products Inc | Q2 2026 | - | - |
| PEERS TOTAL | +5.2 % | - |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Hartman Vreit Xxi Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Hartman Vreit Xxi Inc | Q4 2022 | +0.0 % | - |
| United Health Products Inc | Q2 2026 | - | - |
Hartman Vreit Xxi Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Hartman Vreit Xxi Inc | - | - | - |
| United Health Products Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Hartman Vreit Xxi Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Hartman Vreit Xxi Inc | - | 21.01 |
| United Health Products Inc | - | 25,434.63 |
| PEERS AVERAGE | - | 21.79 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.